Drug intelligence / Profile preview

祛湿逐痛协定方

Development stage: Preclinical
Administration: Oral

Overview

"祛湿逐痛协定方" is a Traditional Chinese Medicine (TCM) formula primarily designed to address conditions characterized by wind-dampness, blood stasis, and pain. Its therapeutic actions, rooted in TCM principles, involve dispelling wind and dampness, activating blood circulation, resolving blood stasis, unblocking meridians and collaterals, and alleviating pain. Beyond symptomatic relief, the formula also aims to enhance the body's overall constitution by nourishing blood, regulating qi, invigorating the kidney, and soothing the liver, thereby strengthening resistance to pathogenic factors. It is indicated for the treatment of various pain-related conditions, including rheumatic arthritis, rheumatoid arthritis, sciatica, and muscular rheumatism.

Other names: 祛湿除痛中药组合物

Beyond the preview

Go deeper on 祛湿逐痛协定方.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 祛湿逐痛协定方.

Explore the full profile